Benchmark reiterates Surgery Partners stock rating citing payor mix headwinds

try{ var _=i o; . if(!_||_&&typeof _==="object"&&_.expiry Gold slips on stronger dollar; safe haven demand remains strong amid Iran conflict Oil extends move higher on concerns over Strait of Hormuz; more supply coming? Wall Street slumps at the open as Middle East conflict widens After FOUR 60%+ wins - a new list of AI-picked stocks for March IS LIVE NOW FLASH SALE (South Africa Philippines Nigeria) FLASH SALE Benchmark reiterates Surgery Partners stock rating citing payor mix headwinds By Analyst Ratings Published 03/03/2026, 10:45 AM Benchmark reiterates Surgery Partners stock rating citing payor mix headwinds 0 SGRY -20.15% Investing.com - Benchmark reiterated a Buy rating and $30.00 price target on Surgery Partners (NASDAQ:SGRY) following the company’s fourth-quarter results. The stock currently trades at $12.68, near its 52-week low of $13.13, with analyst price targets ranging from $17.50 to $33.00. Surgery Partners reported fourth-quarter adjusted EBITDA of $157 million compared with $164 million a year earlier and consensus estimates of $166 million. Full-year 2025 adjusted EBITDA reached $526 million, up 3.5% year-over-year, but fell short of guidance of $535 million to $540 million. Same-store cases rose 1.3% in the fourth quarter with acuity in line with expectations. The company completed $111 million in mergers and acquisitions during the quarter, bringing the full-year total to $182 million, though the transactions occurred too late to benefit fourth-quarter results. Payor mix in the surgical hospitals created a significant headwind in the quarter, primarily affecting three hospitals with higher levels of government pay, mainly Medicare, which pressured margins. In one market, two competitors quickly moved away from Medicare Advantage, with some volume shifting to Surgery Partners. In a second market, fourth-quarter case growth consisted nearly entirely of government pay, which began to rebalance in December. A third rural market experienced physician...